Drugs.com - Pharma Industry News

HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia

THURSDAY, Feb. 6, 2025 -- For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ejaculatory function...

Feb 9, 2025 - 21:45
 0
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
THURSDAY, Feb. 6, 2025 -- For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ejaculatory function...
Read More

Tags:

Previous Article

Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer

Next Article

Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB

Related Posts

2.3 Million New Female Breast Cancer Cases Seen Globally in 2022

2.3 Million New Female Breast Cancer Cases Seen Globall...

Feb 25, 2025  0

Number of Family Caregivers Supporting Older Adults Increasing

Number of Family Caregivers Supporting Older Adults Inc...

Feb 21, 2025  0

Prescriptions for Obesity Management Drugs Increasing

Prescriptions for Obesity Management Drugs Increasing

Feb 9, 2025  0